[1]
CS, R.K. et al. 2024. Pure Red Cell Aplasia - Post Major ABO Incompatible Allogenic Stem Cell Transplantation Role of Ibrutinib. Journal of Stem Cell Therapy and Transplantation. 8, 1 (Jul. 2024), 038–041. DOI:https://doi.org/10.29328/journal.jsctt.1001041.